Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
Carolyn F. Deacon
Topics & Concepts
MedicineIncretinDipeptidyl peptidase-4 inhibitorTolerabilityType 2 Diabetes MellitusDipeptidyl peptidase-4Diabetes mellitusDipeptidyl peptidaseInternal medicineType 2 diabetesGlucagon-like peptide-1GlucagonAdverse effectPharmacologyEndocrinologyInsulinBiochemistryEnzymeBiologyDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisNeuropeptides and Animal Physiology